Article Information
History
- October 31, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Veera M. Rajagopal1,
- Kyoko Watanabe1,
- Joelle Mbatchou1,
- Ariane Ayer1,
- Peter Quon2,
- Deepika Sharma1,
- Michael D. Kessler1,
- Kavita Praveen1,
- Sahar Gelfman1,
- Neelroop Parikshak1,
- Jacqueline M. Otto1,
- Suyin Bao1,
- Shek Man Chim2,
- Elias Pavlopoulos2,
- Andreja Avbersek2,
- Manav Kapoor1,
- Esteban Chen1,
- Marcus B. Jones1,
- Michelle Leblanc1,
- Jonathan Emberson3,4,
- Rory Collins3,
- Jason Torres3,4,
- Pablo Kuri Morales5,
- Roberto Tapia-Conyer5,
- Jesus Alegre5,
- Jaime Berumen5,
- GHS-REGN DiscovEHR collaboration,
- Regeneron Genetics Center,
- Alan R. Shuldiner1,
- Suganthi Balasubramanian1,
- Goncalo R. Abecasis1,
- Hyun M. Kang1,
- Jonathan Marchini1,
- Eli A. Stahl1,
- Eric Jorgenson1,
- Robert Sanchez2,
- Wolfgang Liedtke2,
- Matthew Anderson2,
- Michael Cantor1,
- David Lederer2,
- Aris Baras1,* and
- Giovanni Coppola1,*
- 1Regeneron Genetics Center, Tarrytown, New York, USA
- 2Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA
- 3Clinical Trial Service Unit & Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK
- 4MRC Population Health Research Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK
- 5Experimental Research Unit from the Faculty of Medicine (UIME), National Autonomous University of Mexico (UNAM)
- ↵*Corresponding author Correspondence
Giovanni Coppola giovanni.coppola{at}regeneron.com, Aris Baras aris.baras{at}regeneron.com